The UK BioIndustry Association has written to the new government of prime minister Boris Johnson stressing the importance of having the necessary transport capacity for medicines in place if the UK leaves the EU without a deal on 31 October.
The association said it had called on the government to update the R&D tax credit scheme to boost investment in capital projects and research, and had sent ministers evidence that...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?